ArticleProceedings of the National Academy of Sciences of the United States of America2025

Correction for Ota et al., Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.